ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation (ECPR) During Refractory Out-of-Hospital Cardiac Arrest
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 221
- 试验地点
- 5
- 主要终点
- Hospital Survival
研究概览
简要总结
Hypothesis: Implantation of on-scene ECPR by the HEMS teams in patients with sustained out-of-hospital cardiac arrest, results in the rapid return of circulation and, thus, improved survival and less neurological impairment, which is associated with lower health care costs.
详细描述
Rationale: Approximately half of all cardiac arrest patients achieve return of spontaneous circulation (ROSC) within 10 minutes. However, If ROSC is not achieved within 20 minutes, favourable neurological outcome is rare. Currently, patients without ROSC at scene die at scene, or are transported (while still in cardiac arrest) to the hospital. In the hospital, advanced life support is continued, or, when presented to selected hospitals capable for this strategy, patients receive Extracorporeal CardioPulmonary Resuscitation (ECPR). ECPR is a strategy in which a miniaturized heart-lung machine (similar to that used in open-heart surgery) is attached to the patient. Nowadays, the greatest drawback transporting OHCA patients with refractory arrest to the hospital are the low quality of thorax compression during transport and long time needed to arrive in the hospital, in part because not all hospitals are able to provide this treatment. In the Netherlands, Helicopter Emergency Medical Services (HEMS) deliver highly specialized medical care to trauma and non-trauma patients, covering the entire country.
Hypothesis
Implantation of on-scene ECPR by the HEMS teams in patients with sustained out-of-hospital cardiac arrest, results in the rapid return of circulation and, thus, improved survival and less neurological impairment, which is associated with lower health care costs.
Objective
To improve survival to hospital discharge and costs/QALY in young patients with OHCA by decreasing the time in cardiac arrest by initiating ECPR on scene.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- Age between 18 and 50 years, known or as estimated at inclusion by the HEMS physician.
- •Witnessed arrest (last seen well <5 min), OR signs of life (gasping, movement)
- •Initial rhyme is VT/VF OR Suspected of having a pulmonary embolism
- •Refractory cardiac arrest lasting longer than 20 minutes and shorter than 45 min
- •If age is not exactly known at inclusion and is estimated by the HEMS physician between 18 and 50 years but finally the patient appears to be younger or older, the patient will not be excluded.
排除标准
- •- CO2 et<1.2 kPa (10 mmHg) during CPR
- •No clear echographic visualisation of either the femoral artery or the femoral vein.
- •Expected time from collapse to arrival at an ECPR center with a direct available ECPR team is less than 30 min.
- •The following patients will be withdrawn after initial inclusion as soon as the following information becomes available:
- •Known malignancy
- •Known intracranial haemorrhage/ischemia <6 weeks
- •Care dependent for daily activities before arrest
- •Patients with a "do not resuscitate" order, which was not known at time of the arrest.
- •Refusal of deferred consent by the next of kin or by the patient himself to use the data. Deferred consent will not be asked to relatives of patients who die in scene, but are included in the study.
结局指标
主要结局
Hospital Survival
时间窗: Hospital discharge (on average 6 weeks)
(% patients surviving hospital discharge)
Hospital Survival
时间窗: Hospital discharge (on average 6 weeks)
(% patients surviving hospital discharge)
次要结局
- Survival prehospital ECPR vs ECPR at the hospital vs no ECPR(Hospital discharge (on average 6 weeks after cardiac arrest))
- Favourable neurological outcome (CPC 1-2)(6 months after cardiac arrest)
- Survival prehospital ECPR vs ECPR at the hospital vs no ECPR(Hospital discharge (on average 6 weeks after cardiac arrest))
研究者
Dinis Reis Miranda
Principal Investigator
Erasmus Medical Center